NCT05808543 BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants
| NCT ID | NCT05808543 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guy's and St Thomas' NHS Foundation Trust |
| Condition | Hearing Loss, Sensorineural |
| Study Type | INTERVENTIONAL |
| Enrollment | 272 participants |
| Start Date | 2023-07-27 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 272 participants in total. It began in 2023-07-27 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the BEARS clinical trial is to determine whether using the directional listening training delivered via the BEARS training package for 3-months alongside usual care compared to only receiving usual care improves speech-in-noise perception, hearing experiences, vocabulary and quality of life and reduces listening effort in young people between 8-16 years old (inclusive) with two cochlear implants. The participants will complete hearing assessments and questionnaires before completing the 3-month intervention. They will be followed up for the next 9-months through online and in-person appointments.
Eligibility Criteria
Inclusion Criteria: 1. Participant is a simultaneous or sequential bilateral cochlear implant user\*, who either has: 1. Congenital severe/profound bilateral sensorineural hearing loss and have received at least one implant ≤ 36 months of age. 2. Progressive or acquired severe/profound bilateral sensorineural hearing loss (no age at implant restrictions for these patients) \*(a bilateral CI user is defined as a patient who uses both cochlear implant processors for a minimum of 6-hours per day over a month) 2. Participant has stable programmes (defined as no longer using progressive programmes to work through). 3. Participant has had at least two usual care checks/clinical appointments with stable aided levels (+/- 10 dB across 500Hz-4kHz) and no progressive maps to still work through, if they have had re-implantation of internal implant devices. 4. Participant is aged 8-16 years, inclusive. Exclusion Criteria: 1. Participant (or parent/legal representative) does not speak/understand English sufficiently to undertake assessments. 2. Participant has an intellectual disability at a level that would prevent their ability to understand the trial the intervention or assessment questions. 3. Participant has a comorbid condition impacting ability to participate in the intervention and/or outcome assessment. 4. Participant has an audiological profile impacting ability to participate in the intervention and/or outcome assessments. 5. Participant is actively participating in other trials that may affect hearing outcomes or impact their ability to participate in the intervention. 6. Participant is currently or anticipated to receive treatment and/or intervention that may affect hearing outcomes or adapt implant settings/programming. 7. Participant is refusing to consent to trial activities/protocol. 8. Participant is awaiting reimplantation following device failure or infection. 9. Participant is a non-user of one or both implant processors (i.e., must use both processors for a minimum of 6 hours per day over a month). 10. Participant is a fulltime boarder at a boarding school 11. Participant has unresolvable issues found in device checks that render one of the implants unusable. 12. Participant is a female that is pregnant. 13. Participant has a diagnosis of epilepsy or history of seizures of any kind.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05808543 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 16 Years, studying Hearing Loss, Sensorineural. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05808543 currently recruiting?
Yes, NCT05808543 is actively recruiting participants. Contact the research team at dav1000@medschl.cam.ac.uk for enrollment information.
Where is the NCT05808543 trial being conducted?
This trial is being conducted at Birmingham, United Kingdom, Bradford, United Kingdom, Cambridge, United Kingdom, Kilmarnock, United Kingdom and 9 additional locations.
Who is sponsoring the NCT05808543 clinical trial?
NCT05808543 is sponsored by Guy's and St Thomas' NHS Foundation Trust. The trial plans to enroll 272 participants.